Phase II results of an intraocular steroid delivery system for cataract surgery
- 1 June 1999
- journal article
- clinical trial
- Published by Elsevier BV in Ophthalmology
- Vol. 106 (6), 1172-1177
- https://doi.org/10.1016/s0161-6420(99)90262-2
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Randomized clinical trial of a new dexamethasone delivery system (surodex) for treatment of post-cataract surgery inflammationOphthalmology, 1999
- Control of ocular inflammation after cataract extraction with rimexolone 1% ophthalmic suspensionJournal of Cataract & Refractive Surgery, 1997
- Posterior capsule opacificationSurvey of Ophthalmology, 1992
- Recovery of the blood-aqueous barrier after cataract surgery.British Journal of Ophthalmology, 1991
- A study of the causes of non-compliance by patients prescribed eyedrops.British Journal of Ophthalmology, 1990
- Penetration of Topically Applied Dexamethasone Alcohol Into Human Aqueous HumorAmerican Journal of Ophthalmology, 1988
- Compliance with Topical Pilocarpine TreatmentAmerican Journal of Ophthalmology, 1986
- Steroidal and Nonsteroidal Anti-inflammatory AgentsAmerican Journal of Ophthalmology, 1984
- Intraocular fate of dexamethasone disodium phosphate topically applied to the eyes of rabbitsSteroids, 1978
- Ocular Penetration in Rabbits of Topically Applied DexamethasoneAmerican Journal of Ophthalmology, 1974